Research Article
Comprehensive Evaluation of Serum tRF-17-WS7K092 as a Promising Biomarker for the Diagnosis of Gastric Cancer
Table 1
Clinicopathological analysis of tRF-17-WS7K092.
| Parameter | No. of patients | tRF-17-WS7K092 (high) | tRF-17-WS7K092 (low) | value |
| Sex | Male | 99 | 52 | 47 | 0.335 | Female | 37 | 16 | 21 |
| Age (year) | <60 | 36 | 17 | 19 | 0.697 | ≥60 | 100 | 51 | 49 |
| Tumor size | <5 | 98 | 44 | 54 | 0.056 | ≥5 | 38 | 24 | 14 |
| Differentiation grade | Well-moderate | 63 | 27 | 36 | 0.122 | Poor-undifferentiation | 73 | 41 | 32 |
| T stage | T1-T2 | 71 | 27 | 44 | | T3-T4 | 65 | 41 | 24 |
| Lymph node status | Positive | 85 | 52 | 33 | | Negative | 51 | 16 | 35 |
| TNM stage | I-II | 76 | 28 | 48 | | III-IV | 60 | 40 | 20 |
| Nerve/vascular invasion | Positive | 84 | 50 | 34 | | Negative | 52 | 18 | 34 |
|
|
|